BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24648033)

  • 1. The lymph node ratio optimises staging in patients with node positive colon cancer with implications for adjuvant chemotherapy.
    Moug SJ; Oliphant R; Balsitis M; Molloy RG; Morrison DS;
    Int J Colorectal Dis; 2014 May; 29(5):599-604. PubMed ID: 24648033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.
    Baqar AR; Wilkins S; Wang W; Oliva K; McMurrick P
    BMC Cancer; 2020 Aug; 20(1):762. PubMed ID: 32795292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery.
    Galizia G; Orditura M; Ferraraccio F; Castellano P; Pinto M; Zamboli A; Cecere S; De Vita F; Pignatelli C; Lieto E
    World J Surg; 2009 Dec; 33(12):2704-13. PubMed ID: 19760316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
    Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
    World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dukes C colorectal cancer: is the metastatic lymph node ratio important?
    Thomas M; Biswas S; Mohamed F; Chandrakumaran K; Jha M; Wilson R
    Int J Colorectal Dis; 2012 Mar; 27(3):309-17. PubMed ID: 22065110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Lymph Node Retrieval and Ratio on the Long-Term Survival and Recurrence of Colon Cancer.
    Rao A; Dadras M; Razzak MA; Ahmad K; Vijayasekar C
    J Coll Physicians Surg Pak; 2016 Jun; 26(6):467-70. PubMed ID: 27353981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection.
    Parnaby CN; Scott NW; Ramsay G; MacKay C; Samuel L; Murray GI; Loudon MA
    Br J Cancer; 2015 Jul; 113(2):212-9. PubMed ID: 26079302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.
    Dolan RD; McSorley ST; Horgan PG; McMillan DC
    Medicine (Baltimore); 2018 Mar; 97(13):e0185. PubMed ID: 29595652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):474-479. PubMed ID: 32575943
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer.
    Huh JW; Kim CH; Kim HR; Kim YJ
    J Surg Oncol; 2012 Feb; 105(2):125-9. PubMed ID: 21837680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
    Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
    J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
    Gleisner AL; Mogal H; Dodson R; Efron J; Gearhart S; Wick E; Lidor A; Herman JM; Pawlik TM
    J Am Coll Surg; 2013 Dec; 217(6):1090-100. PubMed ID: 24045143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
    van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
    Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients].
    Zheng W; Zhang L; Wu YL; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):679-683. PubMed ID: 30293393
    [No Abstract]   [Full Text] [Related]  

  • 15. The prognostic impact of the log odds of positive lymph nodes in colon cancer.
    Arslan NC; Sokmen S; Canda AE; Terzi C; Sarioglu S
    Colorectal Dis; 2014 Nov; 16(11):O386-92. PubMed ID: 24980876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked impact of tumor location on the appropriate cutoff values and the prognostic significance of the lymph node ratio in stage III colon cancer: a multi-institutional retrospective analysis.
    Shinto E; Ike H; Hida JI; Kobayashi H; Hashiguchi Y; Kajiwara Y; Hase K; Ueno H; Sugihara K
    J Gastroenterol; 2019 Jul; 54(7):597-607. PubMed ID: 30607613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity of predicting prognosis by the lymph node ratio in node-positive colon cancer.
    Sugimoto K; Sakamoto K; Tomiki Y; Goto M; Kojima Y; Komiyama H
    Dig Surg; 2013; 30(4-6):368-74. PubMed ID: 24107470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes.
    Jakob MO; Guller U; Ochsner A; Oertli D; Zuber M; Viehl CT
    BMC Surg; 2018 Oct; 18(1):81. PubMed ID: 30285691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy.
    Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    Anticancer Res; 2018 Aug; 38(8):4877-4882. PubMed ID: 30061263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.